Gray Ghost Ventures

PayLatr is a recurring micro-credit mobile platform offering interest-free monthly credits to low-income households in India to easily pay for retail transactions without cash, credit cards or other pre-paid means. On average, a middle-income household in India spends about 7,000 – 9,000 rupees at any neighborhood store. More than 95 percent of transactions are in cash because most stores do not accept cards and/or users do not have credit cards. Often, households experience cash crunch issues by using up most of their cash for grocery shopping. PayLatr offers monthly credit to improve their household cash flow by providing recurring monthly credit lines at various merchants, via mobile money.

Atikus seeks to improve financial inclusion for micro, small and medium enterprises (“MSMEs”) by deploying institutionally-targeted solutions rooted in technology, data and risk transference. Atikus believes that aligning a market’s financial inclusion efforts amplifies the quantity, quality and availability of the products and services required to further the MSME segment’s future growth and development.

D.light is a solar home lighting and power product developer. The company's solar goods, which include lights, radios, televisions, fans, and other home appliances, are rechargeable solar kits, allowing rural and semi-urban people to access solar-powered lighting and appliances. Their products are designed to improve health, increase productivity, and enhance the quality of life for users.

Babajob.com is job website and mobile portal dedicated to connecting informal sector workers - cooks, maids, drivers, guards, etc.- and employers to India. Babajob's vision is to make the informal labor market efficient by aggregating 100,000s of jobs and millions of job seekers, appropriately matching job posts and job seekers based on proximity, price and social connections and then pushing these matched connections to both parties via the web and mobiles (voice, SMS, UssD, etc).

Founded in 2007 in New Hampshire, USA, PharmaSecure provides technology-enabled solutions for protection against medicine counterfeiting as well as patient engagement and adherence. PharmaSecure has provided IDs to 2.5 billion drug packages across 300 packaging lines for clients including five of the top ten pharmaceutical companies in India and several of the leading anti-malarial drug providers in Nigeria. PharmaSecure’s proven serialization capabilities have enabled some of the leading exporters of drugs in India to meet the regulatory requirements of countries such as India, China, South Korea, Saudi Arabia and the United States. Products coded by PharmaSecure’s solutions are currently being exported to more than 50 countries around the world. PharmaSecure was also one of the first providers to be approved by the Nigerian FDA (NAFDAC) as a provider of the scratch-and-text Mobile Authentication Service (MAS) solution, which has been in place since 2013 for antimalarial and antibiotic drugs sold in the country and has resulted in dramatic reduction in counterfeiting rates. Every month, PharmaSecure engages tens of thousands of patients via text-and-voice based programs that have shown up to a 60 percent increase in adherence. It is currently implementing a project to measure and increase adherence for TB patients in India, supported by USAID and the Gates Foundation via a Grand Challenges in TB Control grant. PharmaSecure’s CEO, Nakul Pasricha, serves as Vice President on the Governing Body of the Authentication Solution Providers’ Association in India. For further information, please visit www.pharmasecure.com or email info@pharmasecure.com.

LifeCity is a membership-based organization that supports the development of green businesses, while educating consumers about green products and services.

Kadmus Pharmaceuticals, Inc., a biopharmaceutical company, commercially exploits endocannabinoid pathways to develop therapeutics. Endocannabinoids are naturally occurring signaling molecules, whose functions include regulating mood, pain, and metabolism. It offers a portfolio of compounds with activity against a range of disorders targeting CNS conditions, metabolic disorders, neuropathic pain, and obesity. The company develops products for various conditions through the inhibition of endocannabinoid degradation and activation of endocannabinoid related pathways and peripheral cannabinoid receptors. It operates in the United States, Canada, and Europe. Kadmus Pharmaceuticals, Inc. was founded in 1998 and is based in Irvine, California.

Oxxon Therapeutics™ (Oxxon) is a company developing the next generation of innovative antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. To date, the company has built an initial pipeline through its patented Hi-8™ PrimeBoost immunotherapy platform, an approach that allows the rapid development of products to selectively stimulate and enhance potent immune responses against disease. The company has successfully completed phase II clinical programmes in melanoma and hepatitis B and has a third development programme underway in HIV. In addition, the company intends to leverage its enabling platform through partnerships with companies developing therapeutic and preventative vaccine products.

Scion Pharmaceuticals is a Biotechnology company.